Cart
sales@molnova.com
LSKL(a)
CAS No. 283609-79-0
LSKL(a) ( —— )
Catalog No. M20897 CAS No. 283609-79-0
LSKL Inhibitor of Thrombospondin (TSP-1) is a peptide derived from the latency-associated peptide inhibits thrombospondin (TSP-1) activation of TGF-β.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 50 | In Stock |
|
| 5MG | 73 | In Stock |
|
| 10MG | 118 | In Stock |
|
| 25MG | 220 | In Stock |
|
| 50MG | 330 | In Stock |
|
| 100MG | 495 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLSKL(a)
-
NoteResearch use only not for human use.
-
Brief DescriptionLSKL Inhibitor of Thrombospondin (TSP-1) is a peptide derived from the latency-associated peptide inhibits thrombospondin (TSP-1) activation of TGF-β.
-
DescriptionLSKL Inhibitor of Thrombospondin (TSP-1) is a peptide derived from the latency-associated peptide inhibits thrombospondin (TSP-1) activation of TGF-β.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorTGFβ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number283609-79-0
-
Formula Weight458.6
-
Molecular FormulaC21H42N6O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (218.05 mM)
-
SMILESCC(C)CC(N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Liao F Li G Yuan W.et al.LSKL peptide alleviates subarachnoid fibrosis and hydrocephalus by inhibiting TSP1-mediated TGF-β1 signaling activity following subarachnoid hemorrhage in rats.Exp Ther Med. 2016 Oct;12(4):2537-2543.
molnova catalog
related products
-
CORM-3
CORM-3 is a water-soluble carbon monoxide-releasing molecule with anti-inflammatory and cardioprotective activity.
-
ADA
ADA is a biological buffer which can serve as a chelator.
-
WYE-687
WYE-687 is an ATP-competitive and selective inhibitor of mTOR with IC50 of 7 nM; blocks mTORC1/pS6K(T389) and mTORC2/P-AKT(S473) but no effect observed on P-AKT(T308).
